Department of Chemistry, Stanford University, Stanford, California 94305, United States.
Stanford Cancer Institute, Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, United States.
Biomacromolecules. 2024 Jul 8;25(7):4305-4316. doi: 10.1021/acs.biomac.4c00373. Epub 2024 May 30.
The delivery of oligonucleotides across biological barriers is a challenge of unsurpassed significance at the interface of materials science and medicine, with emerging clinical utility in prophylactic and therapeutic vaccinations, immunotherapies, genome editing, and cell rejuvenation. Here, we address the role of readily available branched lipids in the design, synthesis, and evaluation of isoprenoid charge-altering releasable transporters (CARTs), a pH-responsive oligomeric nanoparticle delivery system for RNA. Systematic variation of the lipid block reveals an emergent relationship between the lipid block and the neutralization kinetics of the polycationic block. Unexpectedly, iA21A11, a CART with the smallest lipid side chain, isoamyl-, was identified as the lead isoprenoid CART for the transfection of immortalized lymphoblastic cell lines. When administered intramuscularly in a murine model, iA21A11-mRNA complexes induce higher protein expression levels than our previous lead CART, ONA. Isoprenoid CARTs represent a new delivery platform for RNA vaccines and other polyanion-based therapeutics.
将寡核苷酸递送到生物屏障中是材料科学和医学界面上具有前所未有的重要意义的挑战,在预防性和治疗性疫苗接种、免疫疗法、基因组编辑和细胞更新方面具有新兴的临床应用。在这里,我们研究了现成的支化脂质在设计、合成和评估异戊二烯电荷改变释放转运体(CART)中的作用,CART 是一种 pH 响应的寡聚纳米颗粒 RNA 递药系统。脂质嵌段的系统变化揭示了脂质嵌段与聚阳离子嵌段的中和动力学之间的新兴关系。出人意料的是,具有最小脂质侧链异戊基的 iA21A11 被鉴定为用于转染永生淋巴细胞系的先导异戊二烯 CART。当在小鼠模型中肌内给药时,iA21A11-mRNA 复合物诱导的蛋白表达水平高于我们之前的先导 CART ONA。异戊二烯 CART 代表了 RNA 疫苗和其他基于聚阴离子的治疗药物的新递药平台。